Michael Berney, Ph.D.

Microbiology & Immunology

Phone718-430-3020
Emailmichael.berney@einsteinmed.org
Websitehttp://www.einstein.yu.edu/faculty/13308/michael-berney/

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Michael Berney is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Finished
2 Active

Eradicating persistent M. tuberculosis by synthetic lethality of terminal respiratory oxidases
Berney, M.
National Institute of Allergy and Infectious Diseases
11/13/18 → 10/31/21
Project: Research project
Rapid screening for modes-of-action of M. tuberculosis inhibitors by high-throughput metabolic fingerprinting
Berney, M.
National Institute of Allergy and Infectious Diseases
6/11/18 → 5/31/21
Project: Research project
Inhibition of methionine biosynthesis eliminates persistent M. tuberculosis.
Berney, M.
National Institute of Allergy and Infectious Diseases
2/15/16 → 1/31/19
Project: Research project

3227 Citations
29 h-Index
45 Article
3 Chapter
2 Comment/debate
2 Review article
More
- 1 Short survey

Bioenergetic Inhibitors: Antibiotic Efficacy and Mechanisms of Action in Mycobacterium tuberculosis
Hasenoehrl, E. J., Wiggins, T. J. & Berney, M., Jan 11 2021, In: Frontiers in Cellular and Infection Microbiology. 10, 611683.
Research output: Contribution to journal › Review article › peer-review

Open Access
Bioenergetic Inhibitors: Antibiotic Efficacy and Mechanisms of Action in Mycobacterium tuberculosis
Hasenoehrl, E. J., Wiggins, T. J. & Berney, M., Jan 11 2021, In: Frontiers in Cellular and Infection Microbiology. 10, 611683.
Research output: Contribution to journal › Review article › peer-review

Open Access
Dual inhibition of the terminal oxidases eradicates antibiotic-tolerant Mycobacterium tuberculosis
Lee, B. S., Hards, K., Engelhart, C. A., Hasenoehrl, E. J., Kalia, N. P., Mackenzie, J. S., Sviriaeva, E., Chong, S. M. S., Manimekalai, M. S. S., Koh, V. H., Chan, J., Xu, J., Alonso, S., Miller, M. J., Steyn, A. J. C., Grüber, G., Schnappinger, D., Berney, M., Cook, G. M., Moraski, G. C. & 1 others, Pethe, K., Jan 11 2021, In: EMBO Molecular Medicine. 13, 1, e13207.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations
Nanoluciferase reporter mycobacteriophage for sensitive and rapid detection of mycobacterium tuberculosis drug susceptibility
Jain, P., Garing, S., Verma, D., Saranathan, R., Clute-Reinig, N., Gadwa, J., Peterson, C., Hermansky, G., Fernandez, A. A., Asare, E., Weisbrod, T. R., Spencer, E., Mulholland, C. V., Berney, M., Bell, D., Nichols, K. P., Le Ny, A. L. M., Ordway, D., Jacobs, W. R., Somoskovi, A. & 1 others, Minch, K. J., Nov 2020, In: Journal of Bacteriology. 202, 22, e00411-20.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations
Derailing the aspartate pathway of Mycobacterium tuberculosis to eradicate persistent infection
Hasenoehrl, E. J., Rae Sajorda, D., Berney-Meyer, L., Johnson, S., Tufariello, J. A. M., Fuhrer, T., Cook, G. M., Jacobs, W. R. & Berney, M., Dec 1 2019, In: Nature communications. 10, 1, 4215.
Research output: Contribution to journal › Article › peer-review

Open Access
7 Scopus citations